Predictors of Triptan Response in Pediatric Migraine.

Johnson, Hannah F; Goadsby, Peter J; Gelfand, Amy A

Johnson, Hannah F; Goadsby, Peter J; Gelfand, Amy A.

Afiliação

Johnson HF; Vanderbilt University School of Medicine, Nashville, Tennessee.
Goadsby PJ; The Clinical Research Facility, Headache Center, Department of Neurology, University of California, San Francisco, California; The Clinical Research Facility, Headache Group, NIHR-Wellcome Trust Clinical Research Facility, King's College London, UK.
Gelfand AA; The Clinical Research Facility, Headache Center, Department of Neurology, University of California, San Francisco, California; Division of Child Neurology, Department of Neurology, University of California, San Francisco, California. Electronic address: Amy.gelfand@ucsf.edu.

Pediatr Neurol ; 58: 37-40, 2016 05.

Article em En | MEDLINE | ID: mdl-26968976

Assuntos

Transtornos de Enxaqueca/diagnóstico; Transtornos de Enxaqueca/tratamento farmacológico; Serotoninérgicos/uso terapêutico; Triptaminas/uso terapêutico; Adolescente; Feminino; Humanos; Modelos Logísticos; Masculino; Análise Multivariada; Prognóstico; Resultado do Tratamento

Palavras-chave

aura; cranial autonomic symptoms; migraine; pediatrics; triptan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triptaminas / Serotoninérgicos / Transtornos de Enxaqueca Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Pediatr Neurol Assunto da revista: NEUROLOGIA / PEDIATRIA Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google